Danny Glickman

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study”.

The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study

Inflammatory Bowel Diseases(2023)10.1093/ibd/izad151

N/A

0DataRank · unranked

20 citations

Shannon Dalessio, Wesley M. Raup‐Konsavage, Kent E. Vrana, Matthew Coates, Danny Glickman

Reply: “Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?”

Inflammatory Bowel Diseases(2023)10.1093/ibd/izad222

N/A

0DataRank · unranked

1 citations

Shannon Dalessio, Wesley M. Raup‐Konsavage, Kent E. Vrana, Matthew Coates, Danny Glickman

Response to the Letter to the Editor, “Refining the Understanding of Cannabis Impact on Inflammatory Bowel Disease Outcomes: Recommendations for Enhanced Research and Healthcare Practices”

Inflammatory Bowel Diseases(2024)10.1093/ibd/izae228

N/A

0DataRank · unranked

0 citations

Shannon Dalessio, Wesley M. Raup‐Konsavage, Kent E. Vrana, Matthew Coates, Danny Glickman